Press Releases

Nosopharm specializes in the research and development of new anti-infective drugs, today announces that it has secured funding of EUR 870,000 (USD 1.18 million). The company is receiving this funding as part of the OOPERA...

Novartis announced results from the head-to-head Phase III FIXTURE study showing secukinumab an interleukin-17A inhibitor, was significantly superior to Enbrel in moderate-to-severe plaque psoriasis. Enbrel is a current standard-of-care anti-TNF medication approved to treat moderate-to-severe plaque...

BioUtah today released the agenda for the 2013 Utah Life Science Summit Utah’s premier life science event which will be held all day November 6 at the Grand America Hotel in Salt Lake City Utah. ...

Lannett Company Inc. today announced that it and certain selling stockholders intend to offer shares of the Company’s common stock in an underwritten public offering. The proposed offering is subject to market and other conditions...

Cancer vaccine company DCPrime BV today announced that it has entered into a research and optional license agreement with Janssen Pharmaceuticals Inc. The collaboration has been facilitated in conjunction with the Johnson & Johnson London Innovation Centre where a...

Marshall Gerstein & Borun LLP an intellectual property law firm was recognized as Patent Strategy and Management: Team of the Year by LMG Life Sciences during the LMG Life Sciences Awards ceremony held on September 25 2013 at the...

Approval to manufacture highly potent compound for breakthrough pain relief in cancer treatment granted. 23 September 2013, Recipharm Stockholm  is pleased to announce that the company was informed on September 20, 2013 by the R&D-based...